OraLabs Second Amendment to Stock Exchange Agreement

  
    
  
  
    
      OraLabs Holding Corp. (NASDAQ:OLAB) announced that on October 12, 2006, 
      it entered into a Second Amendment (the "Amendment") to the Stock 
      Exchange Agreement dated March 31, 2006 (the "Agreement") with Partner 
      Success Holdings Limited ("PSHL") and Wo Hing Li, sole shareholder of 
      PSHL. The Agreement provides that a party may terminate the Agreement if 
      closing of the transactions does not occur by October 15, 2006. The 
      Amendment extends that date to January 15, 2007. There can be no 
      assurance that the transactions described in the Agreement will close or 
      that a closing will occur by January 15, 2007.
    
    
      OraLabs, Inc. manufactures Ice Drops(R) brands oral care products; Sour 
      Zone(TM) brands sour products; and Lip Rageous(R), Lip Naturals(R), Chap 
      Ice(R), Extra Lip Moisturizer, Leashables(R), Chapgrip(R), Soothe & 
      Shine(R) brands of lip balm. The product line includes breath drops and 
      sprays, sour drops and sprays, lip balms and a variety of private label 
      products. The Company distributes Sanell(TM) hand sanitizer and 
      Eyelieve(TM) sterile eye products. The Company's products are currently 
      sold in the USA nationally as well as numerous foreign countries. The 
      products are sold through wholesale distributors as well as by direct 
      sale to mass retailers, grocery stores, convenience stores and drug 
      stores.
    
    
      Forward-Looking and Cautionary Statements
    
    
      Except for historical information and discussions contained herein, 
      statements included in this release may constitute "forward-looking 
      statements" within the meaning of the Private Securities Litigation 
      Reform Act of 1995. Reference is made in particular to statements 
      regarding anticipated sales growth, expectations regarding financial 
      results for the quarter and expectations regarding future outcomes. 
      These statements are based on the Company's current beliefs and 
      expectations as to such future outcomes. These statements involve a 
      number of risks, uncertainties, and other factors that could cause 
      results to differ materially, as discussed in the Company's filings with 
      the Securities and Exchange Commission.
    
  
OraLabs Holding Corp. (NASDAQ:OLAB) announced that on October 12,
2006, it entered into a Second Amendment (the "Amendment") to the
Stock Exchange Agreement dated March 31, 2006 (the "Agreement") with
Partner Success Holdings Limited ("PSHL") and Wo Hing Li, sole
shareholder of PSHL. The Agreement provides that a party may terminate
the Agreement if closing of the transactions does not occur by October
15, 2006. The Amendment extends that date to January 15, 2007. There
can be no assurance that the transactions described in the Agreement
will close or that a closing will occur by January 15, 2007.

   OraLabs, Inc. manufactures Ice Drops(R) brands oral care products;
Sour Zone(TM) brands sour products; and Lip Rageous(R), Lip
Naturals(R), Chap Ice(R), Extra Lip Moisturizer, Leashables(R),
Chapgrip(R), Soothe & Shine(R) brands of lip balm. The product line
includes breath drops and sprays, sour drops and sprays, lip balms and
a variety of private label products. The Company distributes
Sanell(TM) hand sanitizer and Eyelieve(TM) sterile eye products. The
Company's products are currently sold in the USA nationally as well as
numerous foreign countries. The products are sold through wholesale
distributors as well as by direct sale to mass retailers, grocery
stores, convenience stores and drug stores.

   Forward-Looking and Cautionary Statements

   Except for historical information and discussions contained
herein, statements included in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Reference is made in
particular to statements regarding anticipated sales growth,
expectations regarding financial results for the quarter and
expectations regarding future outcomes. These statements are based on
the Company's current beliefs and expectations as to such future
outcomes. These statements involve a number of risks, uncertainties,
and other factors that could cause results to differ materially, as
discussed in the Company's filings with the Securities and Exchange
Commission.